Microsynth AG

Microsynth (founded in 1989) is a leading European company in the area of nucleic acid synthesis & analysis. The main activities are divided into following three business areas:

1. DNA/RNA Synthesis
2. DNA/RNA Analysis and Sequencing
3. Contract Research/Outsourcing

For almost three decades, the company’s objective has been to serve its customers by delivering products and services of the highest quality, on time and with outstanding service – and all this at competitive prices. Microsynth has subsidiaries in Germany (Microsynth Seqlab GmbH), Austria (Microsynth Austria GmbH) and Switzerland (ecogenics GmbH). Altogether Microsynth employs a staff of about 100 people. 
All branches of Microsynth are ISO 9001:2015 certified. The NGS and Sanger sequencing departments as well as the fragment length analysis and paternity testing services of Microsynth AG (Balgach) are additionally ISO/IEC 17025:2017 accredited (STS 0429). Further, Microsynth AG (Balgach) is authorized by SwissMedic to perform quality control of medicinal products by GMP Sanger sequencing. The oligonucleotide synthesis of Microsynth AG (Balgach) is EN ISO 13485:2016 certified for the analysis, production and distribution of nucleic acids, in-vitro diagnostic (IVD) assays and applications.